Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association

The glucagon-like peptide-1 receptor agonists (GLP-1RAs) were recommended as a monotherapy or combination therapy with oral hypoglycemic agents or basal insulin in the position statement of the Korean Diabetes Association 2017 for pharmacological therapy. Many randomized clinical trials and systemat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Diabetes Metab J
Autors principals: Kim, Hyun Jin, Park, Seok O, Ko, Seung-Hyun, Rhee, Sang Youl, Hur, Kyu-Yeon, Kim, Nan-Hee, Moon, Min Kyong, Lee, Byung-Wan, Kim, Jin Hwa, Choi, Kyung Mook
Format: Artigo
Idioma:Inglês
Publicat: Korean Diabetes Association 2017
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5741550/
https://ncbi.nlm.nih.gov/pubmed/29272081
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4093/dmj.2017.41.6.423
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars